GENE ONLINE|News &
Opinion
Blog

Aduhelm
The FDA and Biogen Taking Heat for Aduhelm’s Approval Process
2022-12-30
CMS’s New Ruling on Biogen’s Aduhelm Restriction Coverage
2022-04-13
GeneOnline’s Top 10 Editor’s Picks for 2021
2021-12-23
EMA Rejects Marketing Authorization Application of Aduhelm
2021-12-20
A New Study Reveals Viagra Could Decrease the Risk of Alzheimer’s Disease
2021-12-08
AC Immune’s Stock Climbs Following Mixed Phase 2 Trial Results for Alzheimer’s Disease Drug
2021-09-01
Aftermath of Biogen’s Alzheimer’s Drug Approval Continues as Some Hospitals, Insurers Refuse Administration
2021-07-18
Biogen’s Controversial Alzheimer’s Drug Wins Historic FDA Approval
2021-06-07
LATEST
Major U.S. Organization BIO Severs Ties With Member WuXi AppTec Amid U.S. Government’s Security Concerns
2024-03-15
Mayo Clinic Researchers Invent Hypothesis-Driven AI for Cancer Research Breakthroughs
2024-03-14
Chinese Biotechs Seeks IPO Growth on US Shores
2024-03-13
Pearl Bio Enters $1 Billion Partnership Agreement with MSD for Biologic Therapies
2024-03-13
German Study Links PFAS Exposure to Adverse Lipid Profiles and Cardiovascular Risk
2024-03-13
Global Pharmaceutical Investment in Asia: A Strategic Focus Amidst Evolving Market Dynamics
2024-03-12
Taiwanese Hospitals Make Strong Showing in “World’s Best Hospitals” Ranking
2024-03-12
EVENT
2024-04-06
Biotech Innovation Funding Networking
Los Angeles, USA
Scroll to Top